Clene to Cease Development of CNM-ZnAg as Covid-19 Treatment
By Denny Jacob Clene Inc. on Tuesday said it will cease further development of CNM-ZnAg as a Covid-19 treatment. The clinical-stage biopharmaceutical company said it will continue to focus its treatment of neurodegenerative…